Food Retail & Distribution

Page 1

Diplomat Pharmacy Inc gives FY 2015 mixed guidance

4:10pm EST

Diplomat Pharmacy Inc:Expects FY 2015 revenue between $2.8 and $3.1 billion.Expects FY 2015 net income between $12 and $14million.Expects FY 2015 Adjusted EBITDA between $63 and $67 million.Expects FY 2015 Adjusted EPS between $0.47 and $0.50.Fy 2015 revenue of $2.8 billion, EBITDA of $49 million, net income of $23 million and EPS of $0.42 - Thomson Reuters I/B/E/S.

Tallinna Kaubamaja AS proposes dividend payment for 2014

8:31am EST

Tallinna Kaubamaja AS:Proposes dividend payment for 2014 of 0.40 euros per share.Proposes record date for 2014 dividend payment as of April 13.

Core-Mark completes acquisition of Karrys Bros., Limited in Canada

8:31am EST

Core-Mark Holding Company Inc:Closed the purchase of substantially all of the assets of Karrys Bros., Limited and certain affiliates for about C$10 million.Annual sales for the acquired business are about C$100 million.

Core-Mark Holding Company Inc gives FY 2015 guidance below analysts' estimates

8:30am EST

Core-Mark Holding Company Inc:Expects annual net sales in FY 2015 to be between $10.7 billion and $11.0 billion.Expects adjusted EBITDA for FY 2015 to be between $125 million and $129 million.Expects diluted earnings per-share for FY 2015 to be between $1.84 and $1.91, which assumes $16 million of estimated LIFO expense.Expects FY 2015 diluted per-share estimates, excluding LIFO expense, are between $2.26 and $2.33.FY 2015 revenue of $11.3 billion, EBITDA of $141 million and EPS of $2.63 - Thomson Reuters I/B/E/S.


  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Analyst Research

Report Title Price
Provider: Bohai Securities Co.,Ltd.
Provider: Wright Reports
Provider: Wright Reports
Provider: GlobalData
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.